Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1963 1
1964 1
1965 2
1968 3
1970 2
1971 2
1972 1
1976 1
1977 1
1978 4
1980 2
1981 5
1982 11
1983 12
1984 17
1985 14
1986 21
1987 13
1988 14
1989 33
1990 23
1991 24
1992 23
1993 16
1994 32
1995 27
1996 41
1997 28
1998 47
1999 31
2000 35
2001 32
2002 62
2003 78
2004 64
2005 33
2006 29
2007 29
2008 34
2009 34
2010 44
2011 32
2012 35
2013 36
2014 51
2015 43
2016 34
2017 37
2018 50
2019 48
2020 39
2021 12
Text availability
Article attribute
Article type
Publication date

Search Results

1,268 results
Results by year
Filters applied: . Clear all
Page 1
Potential of hyperbaric oxygen in urological diseases.
Tanaka T, Minami A, Uchida J, Nakatani T. Tanaka T, et al. Among authors: nakatani t. Int J Urol. 2019 Sep;26(9):860-867. doi: 10.1111/iju.14015. Epub 2019 May 13. Int J Urol. 2019. PMID: 31083787 Review.
Prolyl-hydroxylase inhibitors reconstitute tumor blood vessels in mice.
Nishide S, Uchida J, Matsunaga S, Tokudome K, Yamaguchi T, Kabei K, Moriya T, Miura K, Nakatani T, Tomita S. Nishide S, et al. Among authors: nakatani t. J Pharmacol Sci. 2020 Jun;143(2):122-126. doi: 10.1016/j.jphs.2020.02.010. Epub 2020 Mar 3. J Pharmacol Sci. 2020. PMID: 32199747 Free article.
Establishing a new appropriate intramuscular injection site in the deltoid muscle.
Nakajima Y, Mukai K, Takaoka K, Hirose T, Morishita K, Yamamoto T, Yoshida Y, Urai T, Nakatani T. Nakajima Y, et al. Among authors: nakatani t. Hum Vaccin Immunother. 2017 Sep 2;13(9):2123-2129. doi: 10.1080/21645515.2017.1334747. Epub 2017 Jun 12. Hum Vaccin Immunother. 2017. PMID: 28604191 Free PMC article.
A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations.
Yamaura T, Nakatani T, Uda K, Ogura H, Shin W, Kurokawa N, Saito K, Fujikawa N, Date T, Takasaki M, Terada D, Hirai A, Akashi A, Chen F, Adachi Y, Ishikawa Y, Hayakawa F, Hagiwara S, Naoe T, Kiyoi H. Yamaura T, et al. Among authors: nakatani t. Blood. 2018 Jan 25;131(4):426-438. doi: 10.1182/blood-2017-05-786657. Epub 2017 Nov 29. Blood. 2018. PMID: 29187377 Free article.
Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial.
J-DAVID Investigators, Shoji T, Inaba M, Fukagawa M, Ando R, Emoto M, Fujii H, Fujimori A, Fukui M, Hase H, Hashimoto T, Hirakata H, Honda H, Hosoya T, Ikari Y, Inaguma D, Inoue T, Isaka Y, Iseki K, Ishimura E, Itami N, Ito C, Kakuta T, Kawai T, Kawanishi H, Kobayashi S, Kumagai J, Maekawa K, Masakane I, Minakuchi J, Mitsuiki K, Mizuguchi T, Morimoto S, Murohara T, Nakatani T, Negi S, Nishi S, Nishikawa M, Ogawa T, Ohta K, Ohtake T, Okamura M, Okuno S, Shigematsu T, Sugimoto T, Suzuki M, Tahara H, Takemoto Y, Tanaka K, Tominaga Y, Tsubakihara Y, Tsujimoto Y, Tsuruya K, Ueda S, Watanabe Y, Yamagata K, Yamakawa T, Yano S, Yokoyama K, Yorioka N, Yoshiyama M, Nishizawa Y. J-DAVID Investigators, et al. Among authors: nakatani t. JAMA. 2018 Dec 11;320(22):2325-2334. doi: 10.1001/jama.2018.17749. JAMA. 2018. PMID: 30535217 Free PMC article. Clinical Trial.
Effects of orally active hypoxia inducible factor alpha prolyl hydroxylase inhibitor, FG4592 on renal fibrogenic potential in mouse unilateral ureteral obstruction model.
Kabei K, Tateishi Y, Shiota M, Osada-Oka M, Nishide S, Uchida J, Nakatani T, Matsunaga S, Yamaguchi T, Tomita S, Miura K. Kabei K, et al. Among authors: nakatani t. J Pharmacol Sci. 2020 Mar;142(3):93-100. doi: 10.1016/j.jphs.2019.12.002. Epub 2019 Dec 6. J Pharmacol Sci. 2020. PMID: 31866051 Free article.
1,268 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page